Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · QWT

Prognostic Assessment Software Of Mild Cognitive Impairment

Prognostic assessment software of mild cognitive impairment. Prognostic assessment software of mild cognitive impairment is a prescription-only device that combines information from multiple clinical data sources to produce an output indicative of the likelihood that a patient diagnosed with mild cognitive impairment will progress to more severe forms of cognitive impairment, or will develop dementia, such as Alzheimer’s disease dementia, within a specified period of time. This device is intended for adjunctive use and not intended as a stand-alone diagnostic or prognostic too.

Product / regulatory recordCompanyPathwayDecision dateSource
NEXT-CueK261805
Neuroxt, Inc.510(k) clearanceOct 8, 2026FDA
Source information

Follow the FDA links to view the original records.

All device categories